MYRUSPA Trademark

Trademark Overview


On Tuesday, June 24, 2025, a trademark application was filed for MYRUSPA with the United States Patent and Trademark Office. The USPTO has given the MYRUSPA trademark a serial number of 99249230. The federal status of this trademark filing is REGISTERED as of Tuesday, January 20, 2026. This trademark is owned by Glaxo Group Limited. The MYRUSPA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of of infectious diseases
myruspa

General Information


Serial Number99249230
Word MarkMYRUSPA
Filing DateTuesday, June 24, 2025
Status700 - REGISTERED
Status DateTuesday, January 20, 2026
Registration Number8111017
Registration DateTuesday, January 20, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 2, 2025

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of of infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 24, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type77 - NOT AVAILABLE
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type77 - NOT AVAILABLE
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type77 - NOT AVAILABLE
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Tuesday, June 24, 2025NEW APPLICATION ENTERED
Tuesday, June 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 24, 2025APPLICATION FILING RECEIPT MAILED
Friday, October 24, 2025ASSIGNED TO EXAMINER
Friday, October 24, 2025NON-FINAL ACTION WRITTEN
Friday, October 24, 2025NON-FINAL ACTION E-MAILED
Friday, October 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 30, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 30, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 30, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 31, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 26, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 2, 2025PUBLISHED FOR OPPOSITION
Tuesday, December 2, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 20, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, January 20, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED